Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-DOTA-dPNE PET/CT in Malignant Tumors
NCT06844110Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2025
- Primary completion
- Dec 2025
- Modality
- Antibody-Radionuclide Conjugates
- Countries
- 1
01
Overview
Open-label, single-arm trial of 68Ga-dPNE in cancer, sponsored by Peking Union Medical College Hospital. Primary endpoint: Standardized Uptake Value. Started Mar 2025; status: recruiting.
02
Drugs
68Ga-dPNE
03
Conditions
cancer
Beyond the preview
Go deeper on NCT06844110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06844110.